Adamas Pharmaceuticals, Inc. Recorded Big Gain

Mon, Oct 11, 2021 at 05:30 PM
Adamas Pharmaceuticals, Inc. Recorded Big Gain

Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ) jumped higher at $8.07, representing a gain of 75.1%. On Fri, Oct 08, 2021, ADMS:NASDAQ touched a New 2-Week Intraday Low of $4.49. The stock appeared on our News Catalysts scanner on Mon, Oct 11, 2021 at 04:44 PM in the 'MERGER' category. From Fri, Sep 24, 2021, the stock recorded 40.00% Up Days and 54.55% Green Days

The share price of the company has been moving sideways in recent weeks.

About Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ)

Adamas Pharmaceuticals Inc is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The Company is developing its wholly-owned product candidate, ADS-5102.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.